speb/financial-data huggingface dataset:
ECAT cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 506337444.00
ECAT income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -113059153.00
ECAT income_statement (annual, 2022-12-31) — General And Administrative Expense: 689743.00
ECAT income_statement (annual, 2022-12-31) — Interest Income: 23598814.00
ECAT balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1881367108.00
ECAT balance_sheet (annual, 2022-12-31) — Investments And Advances: 1881367108.00
ECAT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -5975.00
ECAT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -45559328.00
ECAT income_statement (annual, 2022-12-31) — Net Income: -312896552.00
ECAT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -312896552.00
ECAT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -312896552.00
ECAT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -312896552.00
ECAT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -312896552.00
ECAT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -312896552.00
ECAT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -312896552.00
ECAT income_statement (annual, 2022-12-31) — Net Interest Income: 23598814.00
ECAT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -5975.00
ECAT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -5975.00
ECAT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 0.00
ECAT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1701873225.00
ECAT income_statement (annual, 2022-12-31) — Normalized Income: -312896552.00
ECAT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 185867591.00
ECAT income_statement (annual, 2022-12-31) — Operating Revenue: -311169313.00
ECAT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 102382241.00
ECAT cash_flow (annual, 2022-12-31) — Other Non Cash Items: -903967.00
ECAT income_statement (annual, 2022-12-31) — Other Operating Expenses: 1037496.00
ECAT balance_sheet (annual, 2022-12-31) — Other Payable: 4497087.00
ECAT balance_sheet (annual, 2022-12-31) — Payables: 221444578.00
ECAT balance_sheet (annual, 2022-12-31) — Prepaid Assets: 14326.00
ECAT income_statement (annual, 2022-12-31) — Pretax Income: -312896552.00
ECAT balance_sheet (annual, 2022-12-31) — Receivables: 125305410.00
ECAT cash_flow (annual, 2022-12-31) — Repayment Of Debt: -5975.00
ECAT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -45559328.00
ECAT balance_sheet (annual, 2022-12-31) — Retained Earnings: -300196864.00
ECAT income_statement (annual, 2022-12-31) — Selling General And Administration: 689743.00
ECAT balance_sheet (annual, 2022-12-31) — Share Issued: 102382241.00
ECAT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1701873225.00
ECAT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1701873225.00
ECAT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ECAT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
ECAT balance_sheet (annual, 2022-12-31) — Total Assets: 2026094723.00
ECAT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1701873225.00
ECAT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 324221498.00
ECAT income_statement (annual, 2023-12-31) — +Operating Expense: 2520833.00
ECAT income_statement (annual, 2023-12-31) — +Total Revenue: 297441776.00
ECAT balance_sheet (annual, 2023-12-31) — Accounts Payable: 124804145.00
ECAT income_statement (annual, 2023-12-31) — Basic Average Shares: 101347403.00
ECAT income_statement (annual, 2023-12-31) — Basic EPS: 2.91
ECAT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 19407879.00
ECAT balance_sheet (annual, 2023-12-31) — Capital Stock: 1879911949.00
ECAT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 3691166.00
ECAT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 24234166.00
ECAT cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -151812125.00
ECAT balance_sheet (annual, 2023-12-31) — Cash Financial: 3691166.00
ECAT cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 22975.00
ECAT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 371.00
ECAT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 7536271.00
ECAT cash_flow (annual, 2023-12-31) — Change In Payable: 209981.00
ECAT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -375256.00
ECAT cash_flow (annual, 2023-12-31) — Change In Receivables: -1249822.00
ECAT cash_flow (annual, 2023-12-31) — Change In Working Capital: 6144520.00
ECAT cash_flow (annual, 2023-12-31) — Changes In Cash: 4826544.00
ECAT balance_sheet (annual, 2023-12-31) — Common Stock: 1879911949.00
ECAT cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -151812125.00
ECAT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1838694945.00
ECAT cash_flow (annual, 2023-12-31) — Common Stock Payments: -8967481.00
ECAT balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 3709552.00
ECAT income_statement (annual, 2023-12-31) — Diluted Average Shares: 101347403.00
ECAT income_statement (annual, 2023-12-31) — Diluted EPS: 2.91
ECAT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 294920943.00
ECAT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -257.00
ECAT cash_flow (annual, 2023-12-31) — End Cash Position: 24234166.00
ECAT balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1931824010.00
ECAT cash_flow (annual, 2023-12-31) — Financing Cash Flow: -160779606.00
ECAT cash_flow (annual, 2023-12-31) — Free Cash Flow: 165606150.00
ECAT cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -132171586.00
ECAT income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -14559948.00
ECAT income_statement (annual, 2023-12-31) — General And Administrative Expense: 1963709.00
ECAT income_statement (annual, 2023-12-31) — Interest Expense: 868.00
ECAT income_statement (annual, 2023-12-31) — Interest Income: 32299366.00
ECAT balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 1933902550.00
ECAT balance_sheet (annual, 2023-12-31) — Investments And Advances: 1933902550.00
ECAT cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
ECAT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -8967481.00
ECAT income_statement (annual, 2023-12-31) — Net Income: 294920943.00
ECAT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 294920943.00
ECAT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 294920943.00
ECAT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 294920943.00
ECAT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 294920943.00
ECAT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 294920943.00
ECAT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 294920943.00
ECAT income_statement (annual, 2023-12-31) — Net Interest Income: 32298498.00
ECAT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
ECAT cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
ECAT cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 0.00
ECAT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1838694945.00
ECAT income_statement (annual, 2023-12-31) — Normalized Income: 294920943.00
ECAT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 165606150.00
ECAT income_statement (annual, 2023-12-31) — Operating Revenue: 297441776.00
ECAT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 101893121.00
ECAT cash_flow (annual, 2023-12-31) — Other Non Cash Items: -3287727.00
ECAT income_statement (annual, 2023-12-31) — Other Operating Expenses: 557124.00
ECAT balance_sheet (annual, 2023-12-31) — Other Payable: 3052946.00
ECAT balance_sheet (annual, 2023-12-31) — Payables: 127857091.00
ECAT balance_sheet (annual, 2023-12-31) — Prepaid Assets: 389582.00
ECAT income_statement (annual, 2023-12-31) — Pretax Income: 294920943.00
ECAT balance_sheet (annual, 2023-12-31) — Receivables: 19322630.00
ECAT cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
ECAT cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -8967481.00
ECAT balance_sheet (annual, 2023-12-31) — Retained Earnings: -41217004.00
ECAT income_statement (annual, 2023-12-31) — Selling General And Administration: 1963709.00
ECAT balance_sheet (annual, 2023-12-31) — Share Issued: 101893121.00
ECAT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1838694945.00
ECAT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1838694945.00
ECAT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ECAT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
ECAT balance_sheet (annual, 2023-12-31) — Total Assets: 1977848928.00
ECAT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1838694945.00
ECAT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 139153983.00
ECAT balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
ECAT income_statement (annual, 2024-12-31) — +Operating Expense: 4005724.00
ECAT income_statement (annual, 2024-12-31) — +Total Revenue: 244601144.00
ECAT balance_sheet (annual, 2024-12-31) — Accounts Payable: 138230826.00
ECAT balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 138230826.00
ECAT income_statement (annual, 2024-12-31) — Basic Average Shares: 101517055.00
ECAT income_statement (annual, 2024-12-31) — Basic EPS: 2.37
ECAT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 24234166.00
ECAT balance_sheet (annual, 2024-12-31) — Capital Stock: 1587053372.00
ECAT balance_sheet (quarterly, 2024-12-31) — Capital Stock: 1587053372.00
ECAT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 4272062.00
ECAT balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 4272062.00
ECAT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 28238062.00
ECAT balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 28238062.00
ECAT cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -288411001.00
ECAT balance_sheet (annual, 2024-12-31) — Cash Financial: 4272062.00
ECAT balance_sheet (quarterly, 2024-12-31) — Cash Financial: 4272062.00
ECAT cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -17055.00
ECAT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -3102614.00
ECAT cash_flow (annual, 2024-12-31) — Change In Payable: 887841.00
ECAT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 373959.00
ECAT cash_flow (annual, 2024-12-31) — Change In Receivables: 1756644.00
ECAT cash_flow (annual, 2024-12-31) — Change In Working Capital: -101225.00
ECAT cash_flow (annual, 2024-12-31) — Changes In Cash: 4039693.00
ECAT balance_sheet (annual, 2024-12-31) — Common Stock: 1587053372.00
ECAT balance_sheet (quarterly, 2024-12-31) — Common Stock: 1587053372.00
ECAT cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -288411001.00
ECAT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1744896018.00
ECAT balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 1744896018.00
ECAT cash_flow (annual, 2024-12-31) — Common Stock Payments: -45983346.00
ECAT balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 4997264.00
ECAT balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 4997264.00
ECAT income_statement (annual, 2024-12-31) — Diluted Average Shares: 101517055.00
ECAT income_statement (annual, 2024-12-31) — Diluted EPS: 2.37
ECAT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 240595420.00
ECAT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -35797.00
ECAT cash_flow (annual, 2024-12-31) — End Cash Position: 28238062.00
ECAT balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1854863631.00
ECAT balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1854863631.00
ECAT cash_flow (annual, 2024-12-31) — Financing Cash Flow: -334394347.00
ECAT cash_flow (annual, 2024-12-31) — Free Cash Flow: 338434040.00
ECAT cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 100323900.00
ECAT income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 99188697.00
ECAT income_statement (annual, 2024-12-31) — General And Administrative Expense: 3069543.00
ECAT income_statement (annual, 2024-12-31) — Interest Expense: 1330.00
ECAT income_statement (annual, 2024-12-31) — Interest Income: 28438100.00
ECAT balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 1860712422.00
ECAT balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 1860712422.00
ECAT balance_sheet (annual, 2024-12-31) — Investments And Advances: 1860712422.00
ECAT balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 1860712422.00
ECAT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -45983346.00
ECAT income_statement (annual, 2024-12-31) — Net Income: 240595420.00
ECAT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 240595420.00
ECAT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 240595420.00
ECAT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 240595420.00
ECAT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 240595420.00
ECAT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 240595420.00
ECAT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 240595420.00
ECAT income_statement (annual, 2024-12-31) — Net Interest Income: 28436770.00
ECAT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 0.00
ECAT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1744896018.00
ECAT balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 1744896018.00
ECAT income_statement (annual, 2024-12-31) — Normalized Income: 240595420.00
ECAT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 338434040.00
ECAT income_statement (annual, 2024-12-31) — Operating Revenue: 244601144.00
ECAT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 99345793.00
ECAT balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 99345793.00
ECAT cash_flow (annual, 2024-12-31) — Other Non Cash Items: -2384055.00
ECAT income_statement (annual, 2024-12-31) — Other Operating Expenses: 936181.00
ECAT balance_sheet (annual, 2024-12-31) — Other Payable: 3919240.00
ECAT balance_sheet (quarterly, 2024-12-31) — Other Payable: 3919240.00
ECAT balance_sheet (annual, 2024-12-31) — Payables: 142150066.00
ECAT balance_sheet (quarterly, 2024-12-31) — Payables: 142150066.00
ECAT balance_sheet (annual, 2024-12-31) — Prepaid Assets: 15623.00
ECAT balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 15623.00
ECAT income_statement (annual, 2024-12-31) — Pretax Income: 240595420.00
ECAT balance_sheet (annual, 2024-12-31) — Receivables: 7531046.00
ECAT balance_sheet (quarterly, 2024-12-31) — Receivables: 7531046.00
ECAT cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -45983346.00
ECAT balance_sheet (annual, 2024-12-31) — Retained Earnings: 157842646.00
ECAT balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 157842646.00
ECAT income_statement (annual, 2024-12-31) — Selling General And Administration: 3069543.00
ECAT balance_sheet (annual, 2024-12-31) — Share Issued: 99345793.00
ECAT balance_sheet (quarterly, 2024-12-31) — Share Issued: 99345793.00
ECAT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1744896018.00
ECAT balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 1744896018.00
ECAT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1744896018.00
ECAT balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 1744896018.00
ECAT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ECAT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
ECAT balance_sheet (annual, 2024-12-31) — Total Assets: 1896497153.00
ECAT balance_sheet (quarterly, 2024-12-31) — Total Assets: 1896497153.00
ECAT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1744896018.00
ECAT balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 1744896018.00
ECAT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 151601135.00
ECAT balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 151601135.00
ECAT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 132361836.00
ECAT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1587053372.00
ECAT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 3381036.00
ECAT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 27522036.00
ECAT balance_sheet (quarterly, 2025-06-30) — Cash Financial: 3381036.00
ECAT balance_sheet (quarterly, 2025-06-30) — Common Stock: 1587053372.00
ECAT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1656681730.00
ECAT balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 15153799.00
ECAT balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1769015415.00
ECAT balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 1771061616.00
ECAT balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1771061616.00
ECAT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1656681730.00
ECAT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 99345793.00
ECAT balance_sheet (quarterly, 2025-06-30) — Other Payable: 3856464.00
ECAT balance_sheet (quarterly, 2025-06-30) — Payables: 136218300.00
ECAT balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 24131.00
ECAT balance_sheet (quarterly, 2025-06-30) — Receivables: 13780675.00
ECAT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 69628358.00
ECAT balance_sheet (quarterly, 2025-06-30) — Share Issued: 99345793.00
ECAT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1656681730.00
ECAT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1656681730.00
ECAT balance_sheet (quarterly, 2025-06-30) — Total Assets: 1812388458.00
ECAT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1656681730.00
ECAT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 155706728.00
ECAT income_statement (annual, 2025-12-31) — +Operating Expense: 1162501.00
ECAT income_statement (annual, 2025-12-31) — +Total Revenue: 216214778.00
ECAT balance_sheet (annual, 2025-12-31) — Accounts Payable: 148846987.00
ECAT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 148846987.00
ECAT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 28238062.00
ECAT balance_sheet (annual, 2025-12-31) — Capital Stock: 1261720892.00
ECAT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1261720892.00
ECAT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 3342529.00
ECAT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 3342529.00
ECAT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 25665529.00
ECAT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 25665529.00
ECAT cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -347607626.00
ECAT balance_sheet (annual, 2025-12-31) — Cash Financial: 3342529.00
ECAT balance_sheet (quarterly, 2025-12-31) — Cash Financial: 3342529.00
ECAT cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 0.00
ECAT cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -192043.00
ECAT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -2241068.00
ECAT cash_flow (annual, 2025-12-31) — Change In Payable: -1002850.00
ECAT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 15277.00
ECAT cash_flow (annual, 2025-12-31) — Change In Receivables: 623260.00
ECAT cash_flow (annual, 2025-12-31) — Change In Working Capital: -2797424.00
ECAT cash_flow (annual, 2025-12-31) — Changes In Cash: -2604355.00
ECAT balance_sheet (annual, 2025-12-31) — Common Stock: 1261720892.00
ECAT balance_sheet (quarterly, 2025-12-31) — Common Stock: 1261720892.00
ECAT cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -347607626.00
ECAT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1608724183.00
ECAT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1608724183.00
ECAT balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 6420964.00
ECAT balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 6420964.00
ECAT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 213368713.00
ECAT cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 31822.00
ECAT cash_flow (annual, 2025-12-31) — End Cash Position: 25665529.00
ECAT balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1729826703.00
ECAT balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1729826703.00
ECAT cash_flow (annual, 2025-12-31) — Financing Cash Flow: -347225251.00
ECAT cash_flow (annual, 2025-12-31) — Free Cash Flow: 344620896.00
ECAT cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 135625215.00
ECAT income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 34620614.00
ECAT income_statement (annual, 2025-12-31) — General And Administrative Expense: 953426.00
ECAT income_statement (annual, 2025-12-31) — Interest Expense: 12767.00
ECAT income_statement (annual, 2025-12-31) — Interest Income: 29186641.00
ECAT balance_sheet (annual, 2025-12-31) — Invested Capital: 1609106558.00
ECAT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1609106558.00
ECAT balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 1731484061.00
ECAT balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 1731484061.00
ECAT balance_sheet (annual, 2025-12-31) — Investments And Advances: 1731484061.00
ECAT balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 1731484061.00
ECAT cash_flow (annual, 2025-12-31) — Issuance Of Debt: 382375.00
ECAT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 382375.00
ECAT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 382375.00
ECAT cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 382375.00
ECAT income_statement (annual, 2025-12-31) — Net Income: 213368713.00
ECAT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 213368713.00
ECAT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 213368713.00
ECAT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 213368713.00
ECAT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 213368713.00
ECAT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 213368713.00
ECAT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 213368713.00
ECAT income_statement (annual, 2025-12-31) — Net Interest Income: 29173874.00
ECAT cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 382375.00
ECAT cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 382375.00
ECAT cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 0.00
ECAT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1608724183.00
ECAT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1608724183.00
ECAT income_statement (annual, 2025-12-31) — Normalized Income: 214698728.56
ECAT cash_flow (annual, 2025-12-31) — Operating Cash Flow: 344620896.00
ECAT income_statement (annual, 2025-12-31) — Operating Revenue: 216214778.00
ECAT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 99468307.00
ECAT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 99468307.00
ECAT cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1575608.00
ECAT income_statement (annual, 2025-12-31) — Other Operating Expenses: 209075.00
ECAT balance_sheet (annual, 2025-12-31) — Other Payable: 2750998.00
ECAT balance_sheet (quarterly, 2025-12-31) — Other Payable: 2750998.00
ECAT balance_sheet (annual, 2025-12-31) — Payables: 151597985.00
ECAT balance_sheet (quarterly, 2025-12-31) — Payables: 151597985.00
ECAT balance_sheet (annual, 2025-12-31) — Prepaid Assets: 346.00
ECAT balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 346.00
ECAT income_statement (annual, 2025-12-31) — Pretax Income: 213368713.00
ECAT balance_sheet (annual, 2025-12-31) — Receivables: 33906632.00
ECAT balance_sheet (quarterly, 2025-12-31) — Receivables: 33906632.00
ECAT income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 1683564.00
ECAT balance_sheet (annual, 2025-12-31) — Retained Earnings: 347003291.00
ECAT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 347003291.00
ECAT income_statement (annual, 2025-12-31) — Selling General And Administration: 953426.00
ECAT balance_sheet (annual, 2025-12-31) — Share Issued: 99468307.00
ECAT balance_sheet (quarterly, 2025-12-31) — Share Issued: 99468307.00
ECAT income_statement (annual, 2025-12-31) — Special Income Charges: -1683564.00
ECAT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1608724183.00
ECAT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1608724183.00
ECAT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1608724183.00
ECAT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1608724183.00
ECAT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -353548.44
ECAT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
ECAT balance_sheet (annual, 2025-12-31) — Total Assets: 1791056568.00
ECAT balance_sheet (quarterly, 2025-12-31) — Total Assets: 1791056568.00
ECAT balance_sheet (annual, 2025-12-31) — Total Capitalization: 1609106558.00
ECAT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1609106558.00
ECAT balance_sheet (annual, 2025-12-31) — Total Debt: 382375.00
ECAT balance_sheet (quarterly, 2025-12-31) — Total Debt: 382375.00
ECAT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1608724183.00
ECAT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1608724183.00
ECAT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 182332385.00
ECAT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 182332385.00
ECAT income_statement (annual, 2025-12-31) — Total Unusual Items: -1683564.00
ECAT income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1683564.00
ECBK cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
ECBK cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
ECBK income_statement (annual, 2021-12-31) — Other Gand A: 684000.00
ECBK income_statement (annual, 2021-12-31) — Other Special Charges: 54000.00
ECBK cash_flow (annual, 2021-12-31) — Pension And Employee Benefit Expense: 2001000.00
ECBK cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
ECBK income_statement (annual, 2021-12-31) — Special Income Charges: -54000.00
ECBK income_statement (annual, 2021-12-31) — Total Unusual Items: -54000.00
ECBK income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -54000.00
ECBK income_statement (annual, 2022-12-31) — +Total Revenue: 25043000.00
ECBK balance_sheet (annual, 2022-12-31) — Accounts Receivable: 2632000.00
ECBK balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -4450000.00
ECBK balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 89286000.00
ECBK cash_flow (annual, 2022-12-31) — Amortization Of Securities: 182000.00
ECBK income_statement (annual, 2022-12-31) — Basic Average Shares: 8456218.00
ECBK income_statement (annual, 2022-12-31) — Basic EPS: 0.32
ECBK cash_flow (annual, 2022-12-31) — Beginning Cash Position: 52975000.00
ECBK balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 5699000.00
ECBK cash_flow (annual, 2022-12-31) — Capital Expenditure: -216000.00
ECBK cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -216000.00
ECBK balance_sheet (annual, 2022-12-31) — Capital Stock: 92000.00
ECBK balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 62350000.00
ECBK balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 62350000.00
ECBK balance_sheet (annual, 2022-12-31) — Cash Equivalents: 58927000.00
ECBK balance_sheet (annual, 2022-12-31) — Cash Financial: 3123000.00
ECBK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 390641000.00
ECBK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -389336000.00
ECBK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 7770000.00
ECBK cash_flow (annual, 2022-12-31) — Change In Account Payable: 687000.00
ECBK cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -769000.00
ECBK cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 2905000.00
ECBK cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -398000.00
ECBK cash_flow (annual, 2022-12-31) — Change In Payable: 687000.00
ECBK cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 687000.00
ECBK cash_flow (annual, 2022-12-31) — Change In Receivables: -1151000.00
ECBK cash_flow (annual, 2022-12-31) — Change In Working Capital: 1099000.00
ECBK cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -1151000.00
ECBK cash_flow (annual, 2022-12-31) — Changes In Cash: 9075000.00
ECBK balance_sheet (annual, 2022-12-31) — Common Stock: 92000.00
ECBK balance_sheet (annual, 2022-12-31) — Common Stock Equity: 162730000.00
ECBK cash_flow (annual, 2022-12-31) — Common Stock Issuance: 79246000.00
ECBK cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
ECBK cash_flow (annual, 2022-12-31) — Deferred Income Tax: -1502000.00
ECBK cash_flow (annual, 2022-12-31) — Deferred Tax: -1502000.00
ECBK cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 302000.00
ECBK cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 302000.00
ECBK income_statement (annual, 2022-12-31) — Diluted Average Shares: 8456218.00
ECBK income_statement (annual, 2022-12-31) — Diluted EPS: 0.32
ECBK income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 2720000.00
ECBK cash_flow (annual, 2022-12-31) — End Cash Position: 62050000.00
ECBK cash_flow (annual, 2022-12-31) — Financing Cash Flow: 390641000.00
ECBK cash_flow (annual, 2022-12-31) — Free Cash Flow: 7554000.00
ECBK balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 249000.00
ECBK income_statement (annual, 2022-12-31) — General And Administrative Expense: 10582000.00
ECBK balance_sheet (annual, 2022-12-31) — Gross PPE: 8148000.00
ECBK balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 77591000.00
ECBK cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1982000.00
ECBK income_statement (annual, 2022-12-31) — Insurance And Claims: 225000.00
ECBK income_statement (annual, 2022-12-31) — Interest Expense: 5515000.00
ECBK income_statement (annual, 2022-12-31) — Interest Income: 29157000.00
ECBK cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 4828000.00
ECBK balance_sheet (annual, 2022-12-31) — Invested Capital: 336730000.00
ECBK cash_flow (annual, 2022-12-31) — Investing Cash Flow: -389336000.00
ECBK balance_sheet (annual, 2022-12-31) — Investments And Advances: 82592000.00
ECBK cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 79246000.00
ECBK cash_flow (annual, 2022-12-31) — Issuance Of Debt: 110000000.00
ECBK balance_sheet (annual, 2022-12-31) — Land And Improvements: 594000.00
ECBK balance_sheet (annual, 2022-12-31) — Leases: 301000.00
ECBK balance_sheet (annual, 2022-12-31) — Long Term Debt: 174000000.00
ECBK balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 174000000.00
ECBK cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 110000000.00
ECBK cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -20000000.00
ECBK balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1554000.00
ECBK cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 79246000.00
ECBK balance_sheet (annual, 2022-12-31) — Net Debt: 111650000.00
ECBK income_statement (annual, 2022-12-31) — Net Income: 2720000.00
ECBK income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 2720000.00
ECBK income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 2720000.00
ECBK income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 2720000.00
ECBK income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 2720000.00
ECBK cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 2720000.00
ECBK income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 2720000.00
ECBK income_statement (annual, 2022-12-31) — Net Interest Income: 23642000.00
ECBK cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -12202000.00
ECBK cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 165000000.00
ECBK cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 90000000.00
ECBK cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -5310000.00
ECBK balance_sheet (annual, 2022-12-31) — Net PPE: 3698000.00
ECBK cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 75000000.00
ECBK balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 162730000.00
ECBK income_statement (annual, 2022-12-31) — Normalized Income: 2720000.00
ECBK income_statement (annual, 2022-12-31) — Occupancy And Equipment: 753000.00
ECBK cash_flow (annual, 2022-12-31) — Operating Cash Flow: 7770000.00
ECBK cash_flow (annual, 2022-12-31) — Operating Gains Losses: -2085000.00
ECBK income_statement (annual, 2022-12-31) — Operating Revenue: 25043000.00
ECBK balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 9175247.00
ECBK balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 249000.00
ECBK balance_sheet (annual, 2022-12-31) — Other Equity Interest: -6973000.00
ECBK cash_flow (annual, 2022-12-31) — Other Non Cash Items: 3555000.00
ECBK income_statement (annual, 2022-12-31) — Other Non Interest Expense: 5674000.00
ECBK balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 5001000.00
ECBK income_statement (annual, 2022-12-31) — Other Special Charges: 3256000.00
ECBK cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: -2001000.00
ECBK balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
ECBK income_statement (annual, 2022-12-31) — Pretax Income: 3496000.00
ECBK income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 846000.00
ECBK cash_flow (annual, 2022-12-31) — Purchase Of Investment: -22628000.00
ECBK balance_sheet (annual, 2022-12-31) — Receivables: 2632000.00
ECBK income_statement (annual, 2022-12-31) — Reconciled Depreciation: 302000.00
ECBK cash_flow (annual, 2022-12-31) — Repayment Of Debt: -20000000.00
ECBK cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
ECBK balance_sheet (annual, 2022-12-31) — Retained Earnings: 80076000.00
ECBK income_statement (annual, 2022-12-31) — Salaries And Wages: 10357000.00
ECBK cash_flow (annual, 2022-12-31) — Sale Of Investment: 10426000.00
ECBK income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 752000.00
ECBK income_statement (annual, 2022-12-31) — Selling General And Administration: 11334000.00
ECBK balance_sheet (annual, 2022-12-31) — Share Issued: 9175247.00
ECBK cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 75000000.00
ECBK income_statement (annual, 2022-12-31) — Special Income Charges: -3256000.00
ECBK cash_flow (annual, 2022-12-31) — Stock Based Compensation: 559000.00
ECBK balance_sheet (annual, 2022-12-31) — Stockholders Equity: 162730000.00
ECBK balance_sheet (annual, 2022-12-31) — Tangible Book Value: 162730000.00
ECBK income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ECBK income_statement (annual, 2022-12-31) — Tax Provision: 776000.00
ECBK income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.22
ECBK balance_sheet (annual, 2022-12-31) — Total Assets: 1064462000.00
ECBK balance_sheet (annual, 2022-12-31) — Total Capitalization: 336730000.00
ECBK balance_sheet (annual, 2022-12-31) — Total Debt: 174000000.00
ECBK balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 162730000.00
ECBK balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 901732000.00
ECBK income_statement (annual, 2022-12-31) — Total Unusual Items: -3256000.00
ECBK income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -3256000.00
ECBK income_statement (annual, 2023-12-31) — +Total Revenue: 25842000.00
ECBK balance_sheet (annual, 2023-12-31) — Accounts Receivable: 3766000.00
ECBK balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -4605000.00
ECBK balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 87431000.00
ECBK cash_flow (annual, 2023-12-31) — Amortization Of Securities: 31000.00
ECBK income_statement (annual, 2023-12-31) — Basic Average Shares: 8466021.00
ECBK income_statement (annual, 2023-12-31) — Basic EPS: 0.53
ECBK cash_flow (annual, 2023-12-31) — Beginning Cash Position: 62050000.00
ECBK balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 5696000.00
ECBK cash_flow (annual, 2023-12-31) — Capital Expenditure: -335000.00
ECBK cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -335000.00
ECBK balance_sheet (annual, 2023-12-31) — Capital Stock: 93000.00
ECBK balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 119036000.00
ECBK balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 119036000.00
ECBK balance_sheet (annual, 2023-12-31) — Cash Equivalents: 115250000.00
ECBK balance_sheet (annual, 2023-12-31) — Cash Financial: 3786000.00
ECBK cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 207840000.00
ECBK cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -157288000.00
ECBK cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 6434000.00
ECBK cash_flow (annual, 2023-12-31) — Change In Account Payable: 1455000.00
ECBK cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -1242000.00
ECBK cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 1668000.00
ECBK cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -405000.00
ECBK cash_flow (annual, 2023-12-31) — Change In Payable: 1455000.00
ECBK cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 1455000.00
ECBK cash_flow (annual, 2023-12-31) — Change In Receivables: -1134000.00
ECBK cash_flow (annual, 2023-12-31) — Change In Working Capital: 310000.00
ECBK cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1134000.00
ECBK cash_flow (annual, 2023-12-31) — Changes In Cash: 56986000.00
ECBK balance_sheet (annual, 2023-12-31) — Common Stock: 93000.00
ECBK balance_sheet (annual, 2023-12-31) — Common Stock Equity: 164901000.00
ECBK cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
ECBK cash_flow (annual, 2023-12-31) — Common Stock Payments: -2225000.00
ECBK cash_flow (annual, 2023-12-31) — Deferred Income Tax: -111000.00
ECBK cash_flow (annual, 2023-12-31) — Deferred Tax: -111000.00
ECBK cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 279000.00
ECBK cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 279000.00
ECBK income_statement (annual, 2023-12-31) — Diluted Average Shares: 8523705.00
ECBK income_statement (annual, 2023-12-31) — Diluted EPS: 0.52
ECBK income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 4456000.00
ECBK cash_flow (annual, 2023-12-31) — End Cash Position: 119036000.00
ECBK cash_flow (annual, 2023-12-31) — Financing Cash Flow: 207840000.00
ECBK cash_flow (annual, 2023-12-31) — Free Cash Flow: 6099000.00
ECBK balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 129000.00
ECBK income_statement (annual, 2023-12-31) — General And Administrative Expense: 13053000.00
ECBK balance_sheet (annual, 2023-12-31) — Gross PPE: 8359000.00
ECBK balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 76979000.00
ECBK cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 2259000.00
ECBK income_statement (annual, 2023-12-31) — Insurance And Claims: 793000.00
ECBK income_statement (annual, 2023-12-31) — Interest Expense: 29986000.00
ECBK income_statement (annual, 2023-12-31) — Interest Income: 54776000.00
ECBK cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 28531000.00
ECBK balance_sheet (annual, 2023-12-31) — Invested Capital: 398901000.00
ECBK cash_flow (annual, 2023-12-31) — Investing Cash Flow: -157288000.00
ECBK balance_sheet (annual, 2023-12-31) — Investments And Advances: 81982000.00
ECBK cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
ECBK cash_flow (annual, 2023-12-31) — Issuance Of Debt: 195000000.00
ECBK balance_sheet (annual, 2023-12-31) — Land And Improvements: 594000.00
ECBK balance_sheet (annual, 2023-12-31) — Leases: 345000.00
ECBK balance_sheet (annual, 2023-12-31) — Long Term Debt: 234000000.00
ECBK balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 234000000.00
ECBK cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 195000000.00
ECBK cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -80000000.00
ECBK balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1724000.00
ECBK cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -2225000.00
ECBK balance_sheet (annual, 2023-12-31) — Net Debt: 114964000.00
ECBK income_statement (annual, 2023-12-31) — Net Income: 4456000.00
ECBK income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 4456000.00
ECBK income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 4456000.00
ECBK income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 4456000.00
ECBK income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 4456000.00
ECBK cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 4456000.00
ECBK income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 4456000.00
ECBK income_statement (annual, 2023-12-31) — Net Interest Income: 24790000.00
ECBK cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 572000.00
ECBK cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 60000000.00
ECBK cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 115000000.00
ECBK cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -2350000.00
ECBK balance_sheet (annual, 2023-12-31) — Net PPE: 3754000.00
ECBK cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -55000000.00
ECBK balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 164901000.00
ECBK income_statement (annual, 2023-12-31) — Normalized Income: 4456000.00
ECBK income_statement (annual, 2023-12-31) — Occupancy And Equipment: 941000.00
ECBK cash_flow (annual, 2023-12-31) — Operating Cash Flow: 6434000.00
ECBK cash_flow (annual, 2023-12-31) — Operating Gains Losses: -21000.00
ECBK income_statement (annual, 2023-12-31) — Operating Revenue: 25842000.00
ECBK balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 9291810.00
ECBK balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 129000.00
ECBK balance_sheet (annual, 2023-12-31) — Other Equity Interest: -6606000.00
ECBK cash_flow (annual, 2023-12-31) — Other Non Cash Items: -51000.00
ECBK income_statement (annual, 2023-12-31) — Other Non Interest Expense: 2911000.00
ECBK balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 5003000.00
ECBK cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: 0.00
ECBK balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
ECBK income_statement (annual, 2023-12-31) — Pretax Income: 5985000.00
ECBK cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
ECBK income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 1355000.00
ECBK cash_flow (annual, 2023-12-31) — Purchase Of Investment: -8292000.00
ECBK balance_sheet (annual, 2023-12-31) — Receivables: 3766000.00
ECBK income_statement (annual, 2023-12-31) — Reconciled Depreciation: 279000.00
ECBK cash_flow (annual, 2023-12-31) — Repayment Of Debt: -80000000.00
ECBK cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -2225000.00
ECBK balance_sheet (annual, 2023-12-31) — Retained Earnings: 83854000.00
ECBK income_statement (annual, 2023-12-31) — Salaries And Wages: 12260000.00
ECBK cash_flow (annual, 2023-12-31) — Sale Of Investment: 8864000.00
ECBK income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 794000.00
ECBK income_statement (annual, 2023-12-31) — Selling General And Administration: 13847000.00
ECBK balance_sheet (annual, 2023-12-31) — Share Issued: 9291810.00
ECBK cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -55000000.00
ECBK cash_flow (annual, 2023-12-31) — Stock Based Compensation: 738000.00
ECBK balance_sheet (annual, 2023-12-31) — Stockholders Equity: 164901000.00
ECBK balance_sheet (annual, 2023-12-31) — Tangible Book Value: 164901000.00
ECBK income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ECBK income_statement (annual, 2023-12-31) — Tax Provision: 1529000.00
ECBK income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
ECBK balance_sheet (annual, 2023-12-31) — Total Assets: 1280335000.00
ECBK balance_sheet (annual, 2023-12-31) — Total Capitalization: 398901000.00
ECBK balance_sheet (annual, 2023-12-31) — Total Debt: 234000000.00
ECBK balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 164901000.00
ECBK balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1115434000.00
ECBK balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
ECBK cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: -250000.00
ECBK cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: -26000.00
ECBK income_statement (annual, 2024-12-31) — +Total Revenue: 26214000.00
ECBK balance_sheet (annual, 2024-12-31) — Accounts Receivable: 4015000.00
ECBK balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -4883000.00
ECBK balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -4883000.00
ECBK balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 86189000.00
ECBK cash_flow (annual, 2024-12-31) — Amortization Of Securities: -63000.00
ECBK balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 4561000.00
ECBK income_statement (annual, 2024-12-31) — Basic Average Shares: 8257014.00
ECBK income_statement (annual, 2024-12-31) — Basic EPS: 0.48
ECBK cash_flow (annual, 2024-12-31) — Beginning Cash Position: 119036000.00
ECBK balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 5696000.00
ECBK balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 5696000.00
ECBK cash_flow (annual, 2024-12-31) — Capital Expenditure: -60000.00
ECBK cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -60000.00
ECBK balance_sheet (annual, 2024-12-31) — Capital Stock: 91000.00
ECBK balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 157717000.00
ECBK balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 157717000.00
ECBK balance_sheet (annual, 2024-12-31) — Cash Equivalents: 151789000.00
ECBK balance_sheet (annual, 2024-12-31) — Cash Financial: 5828000.00
ECBK cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 127642000.00